Zymergen CEO Josh Hoffman on Biofacturing Plus FounderU Startup Math | E1231

Jason Calacanis chats with Zymergen CEO Josh Hoffman about the concept of biofacturing. They delve into Zymergen's journey to going public, their roadmap, and how DNA sequencing and machine learning contribute to biomanufacturing. They also discuss the time it takes to bring new material to market, future predictions, and the importance of human capital in the industry.

Speakers

AI Chat

Jason Calacanis

Host • 53%

Unidentified

Josh Hoffman

Guest • 46%

Partners

Chapters

0:00	Start
1:48	Founder University Startup Math Segment
10:22	When to hire someone else to do a task
15:15	Secureframe - Stream compliance in weeks not months, get $1000 off
16:45	Zymergen CEO Josh Hoffman on Biofacturing
21:50	Why Zymergen went public (development vs. commercialization stage)
24:04	Zymergen's roadmap
26:35	Why DNA sequencing maturity enables commercialization
29:54	Machine learning's contribution to biomanufacturing
33:43	Time to bring new material to market
36:12	Embroker - Save up to 20% off traditional insurance & get an additional 10% off
37:52	Predictions for the next decade
42:53	What human capital is needed for the industry
45:30	Recent acquisitions
48:32	Material science & food manufacturing
50:17	Supplier vs. Brand - Business model discussion
1:05:07	The foundational technologies of biofacturing

Transcript

Clip

Loading transcript...